首页> 外文期刊>Vascular >Comparison of percutaneous ultrasound-accelerated thrombolysis versus catheter-directed thrombolysis in patients with acute massive pulmonary embolism.
【24h】

Comparison of percutaneous ultrasound-accelerated thrombolysis versus catheter-directed thrombolysis in patients with acute massive pulmonary embolism.

机译:急性大面积肺栓塞患者经皮超声加速溶栓与导管定向溶栓的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Acute massive pulmonary embolism (PE) is a life-threatening condition that requires prompt and aggressive interventions, including anticoagulation, catheter-directed thrombolysis (CDT), mechanical thrombectomy, or surgical thromboembolectomy. The aim of this study was to evaluate the treatment outcome in patients with massive PE who were treated with either ultrasound-accelerated thrombolysis using the EkoSonic Endovascular System (EKOS) or CDT intervention. During a recent 10-year period, the clinical records of all patients with massive PE undergoing catheter-directed interventions were evaluated. Patients were divided into two treatment groups: EKOS versus CDT interventions. Comparisons were made with regard to the treatment outcome between the two groups. Twenty-five patients underwent 33 catheter-directed interventions for massive PE during the study period. Among them, EKOS or CDT was performed in 15 (45%) and 18 (55%) procedures, respectively. In the EKOS group, complete thrombus removal was achieved in 100% cases. In the CDT cohort, complete or partial thrombus removal was accomplished in 7 (50%) and 2 (14%) cases, respectively. Comparing treatment success based on thrombus removal, EKOS treatment resulted in an improved treatment outcome compared with the CDT group (p < .02). The mean time of thrombolysis in EKOS and CDT group was 17.4 +/- 5.23 and 25.3 +/- 7.35 hours, respectively (p = .03). The mortality rate in the EKOS and CDT group was 9.1% and 14.2%, respectively (not significant). Treatment-related hemorrhagic complication rates in the EKOS and CDT group were 0% and 21.4%, respectively (p = .02). A significant reduction in Miller scores was noted in both groups following catheter-based interventions. No significant difference in relative Miller score improvement was observed between groups. Ultrasound-accelerated thrombolysis using the EkoSonic system is an effective treatment modality in patients with acute massive PE. When compared with CDT, this treatment modality provides similar treatment efficacy with reduced thrombolytic infusion time and treatment-related complications.
机译:急性大量肺栓塞(PE)是一种危及生命的疾病,需要立即采取积极的干预措施,包括抗凝,导管定向溶栓(CDT),机械血栓切除术或外科血栓栓塞切除术。这项研究的目的是评估使用EkoSonic血管内系统(EKOS)或CDT干预接受超声加速溶栓治疗的大量PE患者的治疗结果。在最近的10年中,评估了所有接受导管引导干预的大面积PE患者的临床记录。将患者分为两个治疗组:EKOS与CDT干预。对两组之间的治疗结果进行了比较。在研究期间,有25例患者接受了33例针对大块PE的导管直接干预。其中,EKOS或CDT分别以15(45%)和18(55%)的程序进行。在EKOS组中,100%的病例完全清除了血栓。在CDT队列中,分别有7例(50%)和2例(14%)病例完全或部分清除了血栓。比较基于血栓清除的治疗成功率,与CDT组相比,EKOS治疗可改善治疗效果(p <.02)。 EKOS组和CDT组的平均溶栓时间分别为17.4 +/- 5.23和25.3 +/- 7.35小时(p = .03)。 EKOS和CDT组的死亡率分别为9.1%和14.2%(不显着)。 EKOS组和CDT组与治疗相关的出血并发症发生率分别为0%和21.4%(p = .02)。在进行基于导管的干预后,两组均发现Miller评分显着降低。两组之间的相对Miller评分改善无明显差异。使用EkoSonic系统的超声加速溶栓术是治疗急性大量PE患者的有效方法。当与CDT相比时,这种治疗方式可提供相似的治疗效果,并减少溶栓溶栓时间和与治疗相关的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号